Target intelligence / Profile preview

HIRA-interacting protein 3 (HIRIP3)

Target
HIRIP3
Molecular classification
Histone chaperone, Chromatin-associated protein, Other (not a receptor, ion channel, transporter, or enzyme)
01

Overview

HIRA-interacting protein 3 (HIRIP3) is a mammalian nuclear protein, identified through its binding to HIRA, which is a core regulator of chromatin organization. HIRIP3 directly interacts with core histones H2A, H2B, and H3, acting as a histone chaperone that assists in chromatin assembly by carrying H2A-H2B complexes and facilitating their deposition onto DNA. It modulates the selectivity of histone phosphorylation, notably enabling CK2 kinase-mediated phosphorylation of H2A at serine 1[2][4][5][7]. HIRIP3 is implicated in chromatin metabolism and has developmental relevance via its interactions within the larger HIRA protein complex, but it is not considered a therapeutic target, receptor, or druggable protein currently. There are no reported drugs, mechanisms of drug action, or associated biomarkers for HIRIP3. Notably, alterations in genes overlapping with or encoding HIRIP3 may contribute to certain developmental syndromes[4][5][6].

Other names
HIRIP3HIRA interacting protein 3HIRA-interacting protein 3
02

Mechanism of action

No drugs target HIRIP3, but mechanistically, it acts as a histone chaperone, facilitating the deposition of H2A-H2B dimers and enabling CK2-dependent phosphorylation of H2A

03

Biological functions

Chromatin assemblyHistone deposition/regulationInteraction with histones H2A, H2B, H3Facilitates CK2-dependent phosphorylation of H2A at serine 1
04

Disease associations

Developmental disorders (candidate for human DiGeorge syndrome due to chromosome 22q11.2 deletion, related possibly through the *HIRA* complex)Chromosome 16p11.2 duplication syndromeChromosome 16p12.2-p11.2 deletion syndromeOther/unknown (not directly implicated in cancer or major disease pathways)

Beyond the preview

Go deeper on HIRA-interacting protein 3 (HIRIP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIRA-interacting protein 3 (HIRIP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call